全文获取类型
收费全文 | 12211篇 |
免费 | 633篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 101篇 |
儿科学 | 191篇 |
妇产科学 | 134篇 |
基础医学 | 1955篇 |
口腔科学 | 147篇 |
临床医学 | 1221篇 |
内科学 | 2905篇 |
皮肤病学 | 172篇 |
神经病学 | 1363篇 |
特种医学 | 506篇 |
外科学 | 1651篇 |
综合类 | 52篇 |
一般理论 | 3篇 |
预防医学 | 623篇 |
眼科学 | 77篇 |
药学 | 831篇 |
中国医学 | 14篇 |
肿瘤学 | 963篇 |
出版年
2023年 | 74篇 |
2022年 | 149篇 |
2021年 | 351篇 |
2020年 | 188篇 |
2019年 | 294篇 |
2018年 | 323篇 |
2017年 | 223篇 |
2016年 | 230篇 |
2015年 | 318篇 |
2014年 | 386篇 |
2013年 | 516篇 |
2012年 | 921篇 |
2011年 | 916篇 |
2010年 | 480篇 |
2009年 | 464篇 |
2008年 | 731篇 |
2007年 | 764篇 |
2006年 | 791篇 |
2005年 | 826篇 |
2004年 | 750篇 |
2003年 | 719篇 |
2002年 | 615篇 |
2001年 | 113篇 |
2000年 | 89篇 |
1999年 | 118篇 |
1998年 | 172篇 |
1997年 | 126篇 |
1996年 | 108篇 |
1995年 | 101篇 |
1994年 | 116篇 |
1993年 | 85篇 |
1992年 | 72篇 |
1991年 | 58篇 |
1990年 | 73篇 |
1989年 | 57篇 |
1988年 | 58篇 |
1987年 | 54篇 |
1986年 | 42篇 |
1985年 | 46篇 |
1984年 | 35篇 |
1983年 | 30篇 |
1982年 | 45篇 |
1981年 | 51篇 |
1980年 | 39篇 |
1979年 | 26篇 |
1978年 | 25篇 |
1977年 | 24篇 |
1976年 | 13篇 |
1974年 | 20篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Philippe Moerman Jean-Pierre Fryns Herwig Van Dijck Joseph M. Lauweryns 《Virchows Archiv : an international journal of pathology》1985,408(1):43-48
Summary Two unrelated patients with severe arthrogryposis multiplex congenita (AMC) who died perinatally, are presented. In both, postmortem examination revealed an intact nervous system and striking dystrophic muscle changes, consistent with congenital muscular dystrophy (CMD). Few similar cases have been reported before, but since the condition is not well known, it seems probable that in the past many have been labeled as mere multiple malformations. The possibility of an underlying muscular disorder, either primary myopathic or neurogenic should be considered in any patient with early lethal AMC. Our findings confirm that the fetal akinesia-arthrogryposis sequence is a nonspecific clinical syndrome resulting from various causes of muscular inactivity in utero. The main objective of this report is to provide reasonable guidelines on how to approach the problem of classification. We favor a pathogenetic approach, depending upon careful sampling of the central nervous system and skeletal muscles at autopsy. 相似文献
72.
Brice Poreau Francis Ramond Radu Harbuz Véronique Satre Claire Barro Claire Vettier Véronique Adouard Julien Thevenon Pierre‐Simon Jouk Charles Coutton Klaus Dieterich 《American journal of medical genetics. Part A》2019,179(4):650-654
The AMME syndrome defined as the combination of Alport syndrome, intellectual disability, midface hypoplasia, and elliptocytosis (AMME) is known to be a contiguous gene syndrome associated with microdeletions in the region Xq22.3q23. Recently, using exome sequencing, missense pathogenic variants in AMMECR1 have been associated with intellectual disability, midface hypoplasia, and elliptocytosis. In these cases, AMMECR1 gene appears to be responsible for most of the clinical features of the AMME syndrome except for Alport syndrome. In this article, we present two unrelated male patients with short stature, mild intellectual disability or neurodevelopmental delay, sensorineural hearing loss, and elliptocytosis harboring small microdeletions identified by array‐CGH involving TMEM164 and AMMECR1 genes and SNORD96B small nucleolar RNA for one patient, inherited from their mothers. These original cases further confirm that most specific AMME features are ascribed to AMMECR1 haploinsufficiency. These cases reporting the smallest microdeletions encompassing AMMECR1 gene provide new evidence for involvement of AMMECR1 in the AMME phenotype and permit to discuss a phenotype related to AMMECR1 haploinsufficiency: developmental delay/intellectual deficiency, midface hypoplasia, midline defect, deafness, and short stature. 相似文献
73.
Pierre Zachary Murielle Ullmann Saadi Djeddi Nicolas Meyer Marie-Josée Wendling Evelyne Schvoerer Fran?oise Stoll-Keller Jean-Pierre Gut 《Journal of clinical virology》2005,34(3):207-10; discussion 216-8
BACKGROUND: Most studies evaluating antibody detection assays are conducted on samples from healthy blood donors but not on samples of hospitalized patients which can show non-specific reactions. OBJECTIVES: To compare the performance of three commercial automated assays for the detection of hepatitis C virus (HCV) antibodies, Monolisa anti-HCV Plus version 2, Axsym anti-HCV 3.0 and Vitros anti-HCV, on a population of hospitalized patients. STUDY DESIGN: The specificity of the assays was prospectively evaluated in 2020 routine serum samples. In order to assign the serostatus of each sample, those giving positive or discordant results were further tested by three immunoblots and by RT-PCR (Roche). Moreover, the sensitivity was evaluated on eight commercial HCV seroconversion panels. RESULTS: The Monolisa, Axsym and Vitros assays showed specificities of 99.64%, 99.12% and 99.33%, respectively. Concerning the sensitivity, among 49 samples, the number of positive results was 21, 24 and 24 for the Monolisa, Axsym and Vitros kits, respectively. The differences were not statistically significant at an alpha risk of 5%. CONCLUSIONS: All assays appeared to be reliable for routine screening, but there were a surprising number of indeterminate samples that could not be resolved by confirmatory tests. 相似文献
74.
Vermeesch JR Melotte C Salden I Riegel M Trifnov V Polityko A Rumyantseva N Naumchik I Starke H Matthijs G Schinzel A Fryns JP Liehr T 《European journal of medical genetics》2005,48(3):319-327
A dysmorphic patient was shown to carry a small supernumerary marker chromosome. Multicolor, centromere-multicolor and regular FISH experiments proved the marker to be an analphoid 12pter derived isochromosome. Microdissection of the marker followed by reverse painting and array CGH analysis showed that the isochromosome contains approximately 6 Mb of 12pter-12p13.31 derived sequence. This is only the second report of a marker with a neocentromere 12pter and the molecular fine mapping of the duplicated region further refines the 12p region defining the Pallister-Killian syndrome phenotype. In addition, we show the feasibility of using microdissected chromosomes or chromosomal fragments to molecularly map the chromosomal breakpoints on array CGH. This technology may aid in the identification of chromosomal translocation breakpoints. 相似文献
75.
76.
Schrander-Stumpel CT Curfs LM Sastrowijoto P Cassidy SB Schrander JJ Fryns JP 《American journal of medical genetics. Part A》2004,(4):333-338
The peroxisome biogenesis disorders (PBDs) with generalized peroxisomal dysfunction include Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). There is clinical, biochemical, and genetic overlap among the three phenotypes, also known as Zellweger spectrum disorders. Clinical distinctions between the phenotypes are not sharply defined. Only limited sources are available to serve as a background for prognosis in PBD, especially in case of prolonged survival. We delineated the natural history of 31 PBD patients (age 1.2-24 years) through systematic clinical and biochemical investigations. We excluded classical ZS from our study, and included all patients with a biochemically confirmed generalized peroxisomal disorder over 1 year of age, irrespective of the previously diagnosed phenotype. The initial clinical suspicion, age at diagnosis, growth, development, neurological symptoms, organ involvements, and survival are summarized. Common to all patients were cognitive and motor dysfunction, retinopathy, sensorineural hearing impairment, and hepatic involvement. Many patients showed postnatal growth failure, 10 patients displayed hyperoxaluria of whom 4 had renal stones. Motor skills ranged from sitting with support to normal gait. Speech development ranged from non-verbal expression to grammatical speech and comprehensive reading. The neurodevelopmental course was variable with stable course, rapid decline with leukodystrophy, spinocerebellar syndrome, and slow decline over a wide range of faculties as outcome profiles. At the molecular level, 21 patients had mutations in the PEX1 gene. The two most common PEX1 mutations were the G843D (c.2528G-->A) missense and the c.2097insT frameshift mutation. Patients having the G843D/G843D or the G843D/c.2097insT genotypes were compared. Patients homozygous for G843D generally had a better developmental outcome. However, one patient who was homozygous for the "mild" G843D mutation had an early lethal disease, whereas two other patients had a phenotype overlapping with the G843D/c.2097insT group. This indicates that next to the PEX1 genotype other yet unknown factors determine the ultimate phenotype. 相似文献
77.
78.
79.
MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma 总被引:3,自引:0,他引:3
Leroy X Zerimech F Zini L Copin MC Buisine MP Gosselin B Aubert JP Porchet N 《American journal of clinical pathology》2002,118(1):47-51
We studied, by immunohistochemical analysis, the expression of MUC1 and epithelial membrane antigen in 44 stage pT1 renal cell carcinomas (RCCs). Six patients had a metastatic evolution. The percentage of stained cells was determined for each tumor. All tumors and normal adjacent renal parenchyma were stained. In normal kidney, distal convoluted tubules and collecting ducts stained strongly with an apical distribution. In tumors, there was a significant statistical correlation of the MUC1 expression level with the nuclear grade and with tumor progression. High-grade tumors had more stained cells than did low-grade tumors. Metastatic tumors also were more stained than nonmetastatic lesions. By using the Kaplan-Meier method and the log-rank test, we observed that patients with fewer than 10% of stained cells had no metastatic evolution. In contrast, patients with 70% or more stained cells had significantly lower metastasis-free survival rates. We conclude that MUC1 is expressed in RCC and is associated with tumor progression in pT1 RCC. 相似文献
80.